Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management.

about

Clinical Data as an Adjunct to Ultrasound Reduces the False-Negative Malignancy Rate in BI-RADS 3 Breast Lesions.Can unenhanced breast MRI be used to decrease negative biopsy rates?Nonmasslike lesions on breast sonography: comparison between benign and malignant lesions.

P2860

Q30373693-7D5DBA49-7123-4F80-814C-EE924C798C98 Q35838218-1E15372F-6A94-41A7-866B-1E7644DEFDD1 Q53137271-29257D07-A954-4FF9-982C-632AD0B89031

P2860

Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management.

Item

http://www.wikidata.org/entity/Q38063836

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Risk of malignancy in palpable ...... : implications for management.

@en

type

Item

label

Risk of malignancy in palpable ...... : implications for management.

@en

prefLabel

Risk of malignancy in palpable ...... : implications for management.

@en

P1476

Risk of malignancy in palpable ...... : implications for management.

@en

P2093

Catherine S Giess

http://www.w3.org/2001/XMLSchema#string

Jack E Meyer

http://www.w3.org/2001/XMLSchema#string

Julie A Ritner

http://www.w3.org/2001/XMLSchema#string

Lisa Zorn Smeglin

http://www.w3.org/2001/XMLSchema#string

Robyn L Birdwell

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical implications of subcategorizing BI-RADS 4 breast lesions associated with microcalcification: a radiology-pathology correlation study

Short-term follow-up of palpable breast lesions with benign imaging features: evaluation of 375 lesions in 320 women.

Evaluation of a palpable breast mass.

Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted?

BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.

BI-RADS 3, 4, and 5 lesions: value of US in management--follow-up and outcome.

Probably benign breast lesions: when should follow-up be recommended and what is the optimal follow-up protocol?

Compliance with recommended follow-up after percutaneous breast core biopsy.

Palpable breast masses with probably benign morphology at sonography: can biopsy be deferred?

Short-interval follow-up mammography versus immediate core biopsy of benign breast lesions: assessment of patient stress.

P304

1943-1949

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7863/JUM.2012.31.12.1943

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23197547

http://www.w3.org/2001/XMLSchema#string

Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management.

about

P2860

P2860

Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698